Imunon, Inc.
IMNN
$3.96
$0.051.15%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -56.48% | -34.27% | -21.61% | -- |
| Gross Profit | -- | 56.48% | 34.27% | 21.61% | -- |
| SG&A Expenses | -5.50% | -29.76% | 15.29% | -20.76% | -13.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.94% | -44.79% | -17.28% | -30.52% | 27.08% |
| Operating Income | 29.94% | 44.79% | 17.28% | 30.52% | -27.08% |
| Income Before Tax | 29.23% | 42.76% | 16.78% | 34.23% | -39.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.23% | 42.76% | 16.78% | 17.00% | -39.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.23% | 42.76% | 16.78% | 17.00% | -39.37% |
| EBIT | 29.94% | 44.79% | 17.28% | 30.52% | -27.08% |
| EBITDA | 30.56% | 45.54% | 17.46% | 30.31% | -27.66% |
| EPS Basic | 68.99% | 71.91% | 46.27% | 46.26% | 22.32% |
| Normalized Basic EPS | 68.99% | 71.91% | 46.26% | 57.41% | 22.32% |
| EPS Diluted | 68.99% | 71.91% | 46.27% | 46.26% | 22.32% |
| Normalized Diluted EPS | 68.99% | 71.91% | 46.26% | 57.41% | 22.32% |
| Average Basic Shares Outstanding | 128.23% | 103.80% | 54.86% | 54.45% | 79.41% |
| Average Diluted Shares Outstanding | 128.23% | 103.80% | 54.86% | 54.45% | 79.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |